Tearsheet

Clorox (CLX)

Market Price (12/4/2025): $105.43 | Market Cap: $12.9 Bil
Sector: Consumer Staples | Industry: Household Products

Clorox (CLX)

Market Price (12/4/2025): $105.43
Market Cap: $12.9 Bil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

Megatrend and thematic drivers
Megatrends include Health & Wellness Trends, and Sustainable Consumption. Themes include Nutritional Supplements, Organic & Natural Products, Show more.

0	Megatrend and thematic drivers Megatrends include Health & Wellness Trends, and Sustainable Consumption. Themes include Nutritional Supplements, Organic & Natural Products, Show more.

Valuation, Metrics & Events

	12/4/25	2024	2023	2022
Share Price CYE	$105.43	$156.53	$132.97	$126.66
Market Cap CYE ($ Bil)	12.9	19.4	16.5	15.6
Total Debt ($ Bil)	3.1	2.9	2.9	2.9
Total Cash ($ Bil)	0.2	0.2	0.2	0.4
Enterprise Value ($ Bil)	15.8	22.3	19.4	18.5
Valuation Ratios
P/S TTM	2.2	2.8	2.5	2.4
P/EBIT TTM	13.8	17.2	36.3	52.9
P/E TTM	19.2	24.8	63.2	116.4
Sector Ratios
P/S TTM (Sector)	0.0	0.0	0.0	0.0
P/EBIT TTM (Sector)	0.0	0.0	0.0	0.0
P/E TTM (Sector)	0.0	0.0	0.0	0.0

	12/4/25	2024
Share Price CYE	$105.43	$156.53
Market Cap CYE ($ Bil)	12.9	19.4
Total Debt ($ Bil)	3.1	2.9
Total Cash ($ Bil)	0.2	0.2
Enterprise Value ($ Bil)	15.8	22.3
Valuation Ratios
P/S TTM	2.2	2.8
P/EBIT TTM	13.8	17.2
P/E TTM	19.2	24.8
Sector Ratios
P/S TTM (Sector)	0.0	0.0
P/EBIT TTM (Sector)	0.0	0.0
P/E TTM (Sector)	0.0	0.0

	CLX	S&P 500
REVENUE GROWTH	VERY POOR
Rev LTM ($ Bil)	6.8
Rev Chg Q	-18.9%	0.8%
Rev Chg LTM	-9.3%	0.8%
Rev Chg 3Y Avg	-1.1%	3.1%
PROFITABILITY	FAIR
Op Inc LTM ($ Bil)	1.0
CFO LTM ($ Bil)	0.9
Net Inc LTM ($ Bil)	0.8
Op Mgn LTM	14.9%	22.0%
CFO/Rev LTM	12.6%	20.7%
Net Inc Mgn	11.7%	10.1%
VALUATION	MODERATE
P/S	2.2	2.1
P/CFO	17.8	9.9
P/FCF	23.8	12.2
P/E	19.2	20.7
STABILITY	GOOD
Debt/Equity	0.20	0.44
Cash/Assets	0.03	0.05

AI Generated Analysis | Feedback

Metric	Value	Date	Source
Market Share Leadership	Approximately 80% of brands hold the #1 or #2 market share position in their respective categories.	12012023	Link
Bleach Market Share	70%	12012023	Link
Charcoal Market Share	50%	12012023	Link
Trash Bag Market Share	33.3%	12012023	Link
Recyclable, Reusable or Compostable Packaging Goal Progress	88% of goal to have 100% recyclable, reusable or compostable packaging by 2025.	2222024	Link
Scope 1 and 2 Greenhouse Gas Emissions Reduction	Greater than 65% reduction versus 2020 base year.	9032024	Link
Scope 3 Greenhouse Gas Emissions Reduction	Greater than 15% reduction in category 1 (purchased goods and services) and category 11 (use of sold products) against a 2020 baseline.	9032024	Link
Zero-Waste-to-Landfill Facilities	More than half of facilities and almost 80% of plants have attained zero-waste-to-landfill status.	9032024	Link
Recordable Incident Rate	0.47	9032024	Link
Consumer Reach	Achieved 2025 goal of knowing 100 million consumers.	9032024	Link
Board of Directors Diversity - Female Representation	50%	2222024	Link
Board of Directors Diversity - People of Color Representation	25%	2222024	Link

Upcoming
1/28/2026	Dividend	Amount: $1.24 Payment On: 2/13/2026
2/02/2026	Earnings Release	Rev: $1.0 Bil (E) EPS: $1.46 (E)

CLX Stock

Return (1M):

Why The Stock Moved

Qualitative Assessment

AI Generated Analysis | Feedback

Here are five key points explaining why Clorox (CLX) stock moved by approximately -10.1% during the period from August 31, 2025, to December 4, 2025: 1. Macroeconomic Headwinds and Weak Consumer Sentiment: A notable weakening of US consumer sentiment, alongside broader macroeconomic and geopolitical uncertainties, directly led to a decline in consumer purchasing behavior, particularly affecting core categories like household cleaning products, resulting in lower-than-expected sales volumes.

2. Strategic Divestitures Impacting Sales: The divestment of Clorox's Better Health Vitamins, Minerals, and Supplements (VMS) business and its operations in Argentina significantly reduced net sales, contributing to an 8% year-over-year decrease in net sales for the third quarter of fiscal year 2025 and continued to impact revenue in the first quarter of fiscal year 2026.

3. Enterprise Resource Planning (ERP) System Transition Disruptions: The company's ERP system transition caused service disruptions that negatively impacted organic sales growth. While there was an initial pull-forward of shipments to retailers, subsequent drawdowns of this inventory were expected to negatively affect sales in fiscal year 2026, contributing to lower organic sales volumes and pricing.

4. Intensified Competition and Retailer Destocking: Increased promotional activities from competitors, especially in product categories such as Glad, challenged Clorox's pricing power and market share. Additionally, retailers reducing their inventory levels, particularly in the household segment, further dampened sales.

5. Cautious Financial Outlook and Analyst Downgrades: Clorox's mixed fiscal year 2025 results and a cautious outlook for fiscal years 2025 and 2026, which anticipated further declines in net sales and earnings per share due to the ERP transition and divestitures, fueled investor apprehension. This was compounded by analysts cutting price targets and a weakening sentiment, leading to a consensus "Reduce" rating for the stock.

Show less

Stock Movement Drivers

Fundamental Drivers

The -13.5% change in CLX stock from 9/3/2025 to 12/3/2025 was primarily driven by a -11.9% change in the company's P/E Multiple.

	9032025	12032025	Change
Stock Price ($)	121.64	105.17	-13.54%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7104.00	6771.00	-4.69%
Net Income Margin (%)	11.40%	11.68%	2.46%
P/E Multiple	18.50	16.30	-11.85%
Shares Outstanding (Mil)	123.17	122.63	0.44%
Cumulative Contribution			-13.54%

LTM = Last Twelve Months as of date shown

Market Drivers

9/3/2025 to 12/3/2025

	Return	Correlation
CLX	-13.5%
Market (SPY)	6.2%	-0.1%
Sector (XLP)	-2.2%	60.0%

Fundamental Drivers

The -17.2% change in CLX stock from 6/4/2025 to 12/3/2025 was primarily driven by a -27.8% change in the company's P/E Multiple.

	6042025	12032025	Change
Stock Price ($)	127.01	105.17	-17.20%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7019.00	6771.00	-3.53%
Net Income Margin (%)	9.89%	11.68%	18.15%
P/E Multiple	22.58	16.30	-27.79%
Shares Outstanding (Mil)	123.37	122.63	0.60%
Cumulative Contribution			-17.20%

LTM = Last Twelve Months as of date shown

Market Drivers

6/4/2025 to 12/3/2025

	Return	Correlation
CLX	-17.2%
Market (SPY)	15.1%	15.5%
Sector (XLP)	-3.5%	61.0%

Fundamental Drivers

The -34.7% change in CLX stock from 12/3/2024 to 12/3/2025 was primarily driven by a -70.8% change in the company's P/E Multiple.

	12032024	12032025	Change
Stock Price ($)	161.08	105.17	-34.71%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7469.00	6771.00	-9.35%
Net Income Margin (%)	4.78%	11.68%	144.41%
P/E Multiple	55.86	16.30	-70.81%
Shares Outstanding (Mil)	123.80	122.63	0.94%
Cumulative Contribution			-34.72%

LTM = Last Twelve Months as of date shown

Market Drivers

12/3/2024 to 12/3/2025

	Return	Correlation
CLX	-34.7%
Market (SPY)	14.3%	19.7%
Sector (XLP)	-2.8%	63.4%

Fundamental Drivers

The -22.7% change in CLX stock from 12/4/2022 to 12/3/2025 was primarily driven by a -60.6% change in the company's P/E Multiple.

	12042022	12032025	Change
Stock Price ($)	136.00	105.17	-22.67%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7041.00	6771.00	-3.83%
Net Income Margin (%)	5.75%	11.68%	103.10%
P/E Multiple	41.42	16.30	-60.63%
Shares Outstanding (Mil)	123.34	122.63	0.58%
Cumulative Contribution			-22.67%

LTM = Last Twelve Months as of date shown

Market Drivers

12/4/2023 to 12/3/2025

	Return	Correlation
CLX	-21.6%
Market (SPY)	53.2%	15.9%
Sector (XLP)	16.4%	58.3%

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
CLX Return	34%	-11%	-17%	5%	18%	-32%	-17%
Peers Return	29%	22%	-16%	15%	4%	-21%	26%
S&P 500 Return	16%	27%	-19%	24%	23%	16%	112%
Monthly Win Rates [3]
CLX Win Rate	58%	42%	50%	58%	50%	20%
Peers Win Rate	62%	55%	40%	43%	58%	32%
S&P 500 Win Rate	58%	75%	42%	67%	75%	70%
Max Drawdowns [4]
CLX Max Drawdown	-1%	-20%	-29%	-15%	-9%	-37%
Peers Max Drawdown	-21%	-9%	-29%	-9%	-6%	-27%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: PG, CL, KMB, ENTG, EPC. See CLX Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)

How Low Can It Go

Unique Key	Event	CLX	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-48.1%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	92.6%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	Not Fully Recovered days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-18.0%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	22.0%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	Not Fully Recovered days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-23.3%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	30.4%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	136 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-33.0%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	49.2%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	583 days	1480 days

Compare to PG, CL, KMB, ENTG, EPC

In The Past

Clorox's stock fell -48.1% during the 2022 Inflation Shock from a high on 1/27/2021. A -48.1% loss requires a 92.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Clorox (CLX)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States. The Household segment provides cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; bags and wraps under the Glad brand name; and grilling products under the Kingsford and Kingsford Match Light brand names in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand name; natural personal care products under the Burt's Bees brand name; and water-filtration systems and filters under the Brita brand name in the United States. The International segment provides laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brand names. The Clorox Company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

AI Generated Analysis | Feedback

Here are 1-3 brief analogies for Clorox:

The Procter & Gamble of household cleaning, charcoal, and pet care products.
Like Unilever, but specializing in brands ranging from Clorox bleach to Burt's Bees and Glad bags.

AI Generated Analysis | Feedback

Clorox Bleach & Cleaning Products: Disinfecting bleaches, wipes, and sprays used for household cleaning and sanitation.
Pine-Sol: Multi-surface cleaners known for their distinctive scent and ability to tackle tough messes.
Glad: Plastic bags, wraps, and containers for food storage, trash management, and general household use.
Kingsford: Charcoal briquets and grilling accessories primarily used for outdoor cooking.
Hidden Valley Ranch: Salad dressings, dips, and seasoning mixes, most famously the original ranch flavor.
Fresh Step: Cat litter products designed to control odors and provide a comfortable environment for pets.
Brita: Water filtration systems, including pitchers, dispensers, and faucet filters, to improve tap water quality.
Burt's Bees: Natural personal care products, such as lip balms, skincare, and bath products.

AI Generated Analysis | Feedback

Clorox (CLX) sells primarily to other companies, specifically major retail chains and e-commerce platforms that distribute its products to individual consumers.

According to its most recent annual filings, Clorox's major customers are:

Walmart Inc. (Symbol: WMT)
The Kroger Co. (Symbol: KR)
Amazon.com, Inc. (Symbol: AMZN)

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

Linda Rendle, Chair and CEO

Linda Rendle was named CEO of The Clorox Company in September 2020 and added responsibilities as chair of the board in January 2024. She has been with Clorox for over 20 years, holding various senior leadership positions. Prior to becoming CEO, she served as president, overseeing all of the company's businesses, corporate and business development, corporate strategy, and five core global functions. Her roles at Clorox have also included executive vice president – Cleaning, International, Strategy and Operations, and vice president and general manager – Home Care. Before joining Clorox in 2003, Rendle worked for The Procter & Gamble Company in sales management.

Luc Bellet, Executive Vice President and Chief Financial Officer

Luc Bellet was appointed Executive Vice President and Chief Financial Officer of The Clorox Company, effective April 1, 2025. He has been with Clorox for over 18 years, most recently serving as the company's treasurer. Bellet has held various leadership roles across Clorox's financial organization, including financial planning and analysis, internal audit, and business development.

Nina Barton, Executive Vice President and Group President – Care & Connection

Nina Barton is the Executive Vice President and Group President – Care & Connection at Clorox.

Angela Hilt, Executive Vice President and Chief Legal and External Affairs Officer and Corporate Secretary

Angela Hilt serves as Executive Vice President and Chief Legal and External Affairs Officer and Corporate Secretary for The Clorox Company.

Chris Hyder, Executive Vice President and Group President — Health & Hygiene

Chris Hyder is the Executive Vice President and Group President — Health & Hygiene at Clorox.

AI Generated Analysis | Feedback

The rapid growth of direct-to-consumer (DTC) and subscription-based brands specializing in eco-friendly, refillable, and plant-based cleaning and household products, which are capturing market share by appealing to evolving consumer preferences for sustainability and convenience.

AI Generated Analysis | Feedback

Addressable Market Sizes for Clorox's Main Products:

Household Cleaning Products (e.g., Clorox Disinfecting Wipes, Clorox Bleach):
- Global Household Cleaning Products Market: USD 270.36 billion in 2024, projected to reach USD 379.76 billion by 2032.
- U.S. Household Cleaning Products Market: Projected to reach an estimated value of USD 85.22 billion by 2032.
- Global Wipes Market: Valued at USD 4.86 billion in 2024, projected to reach USD 8.04 billion by 2032.
- U.S. Wet Wipes Market: Generated USD 6,954.3 million in 2022 and is expected to reach USD 8,542.5 million by 2030.
- Global Bleaching Agents Market: Estimated at USD 887.7 million in 2022 and projected to reach USD 1,350.1 million by 2030.
Cat Litter Products (e.g., Fresh Step, Scoop Away):
- Global Cat Litter Products Market: Estimated at USD 16.41 billion in 2024 and projected to reach USD 22.31 billion by 2030.
- U.S. Cat Litter Products Market: Estimated at USD 4.53 billion in 2024 and projected to reach USD 5.74 billion by 2030.
Grilling Charcoal (e.g., Kingsford):
- Global BBQ Charcoal Market: Stood at US$ 3.25 billion in 2023, projected to reach US$ 5.24 billion by 2033.
- North America BBQ Charcoal Market: Accounted for approximately 48% market share in 2021.
Water Filtration Products (e.g., Brita):
- Global Water Purifier Market: Valued at USD 35.01 billion in 2024, projected to grow to USD 62.88 billion by 2032.
- U.S. Water Purifier Market: Projected to reach an estimated value of USD 10.63 billion by 2032.
- Global Home Water Filtration Unit Market: Valued at USD 12.12 billion in 2022 and projected to reach USD 26.73 billion by 2030.
Natural Personal Care Products (e.g., Burt's Bees):
- Global Natural and Organic Personal Care Market: Generated a revenue of US$ 28.4 billion in 2025, projected to top US$ 54.3 billion by 2032.
- U.S. Natural and Organic Personal Care Market: Projected to be worth US$ 2,222.2 million (US$ 2.22 billion) in 2024.
Insect Repellents (e.g., Repel, STEM):
- Global Insect Repellent Market: Estimated at USD 5.57 billion in 2024 and projected to reach USD 8.28 billion by 2030.
- U.S. Insect Repellent Market: Generated a revenue of USD 376.9 million in 2024 and is expected to reach USD 540.6 million by 2030.
Food Bags and Wraps (e.g., Glad):
- null

AI Generated Analysis | Feedback

The Clorox Company (CLX) is expected to drive future revenue growth over the next 2-3 years through several strategic initiatives:

Product Innovation and New Launches: Clorox plans to introduce new innovations across its major brands, including Glad, Brita, and Burt's Bees, with further product developments anticipated in the latter half of fiscal year 2026 to maintain competitiveness and drive growth. Analysts also note that upcoming product innovation, particularly in premium and wellness platforms, aims to regain market share and foster organic growth.
Strategic Pricing and Margin Management: The company is leveraging disciplined pricing actions and a comprehensive margin-management program to support growth and mitigate cost pressures. Clorox's multi-faceted pricing policy includes premium pricing for core brands and strategic adjustments in categories supported by value and innovation.
Digital Transformation and ERP System Benefits: The successful launch of a new ERP (Enterprise Resource Planning) system in the U.S. is a critical enhancement to Clorox's digital infrastructure. This system is expected to unlock new value streams, strengthen operational capabilities, improve efficiency, and drive sustained margin gains over the next several years.
Reinvigorating Category Growth and Market Share Recovery: After facing disruptions, Clorox is focused on regaining market share and stimulating category growth. The company aims for positive low single-digit organic sales growth in the second half of the fiscal year 2026 and a return to historical category growth rates of 2-2.5%. Efforts are particularly noted in areas like the Glad brand and the Professional Products Division (PPD).
International Market Expansion and Stability: Clorox's international business has shown growth above the company's sales average. The divestiture of the Argentina business is anticipated to reduce volatility and create more stability and growth opportunities in other parts of the world.

AI Generated Analysis | Feedback

Share Repurchases

Clorox had $75 million in share repurchases for the quarter ending June 30, 2025.
Annual share repurchases for fiscal year 2022 were $25 million.
The company has an authorized open-market share repurchase program of up to $2 billion, which was approved in May 2018 and has no expiration date.

Share Issuance

Clorox's issuance of common stock for the latest twelve months ending June 30, 2025, was $26 million.
The average annual issuance of common stock for fiscal years ending June 2021 to 2025 was $33.6 million.
Share issuance peaked at $103 million in fiscal year 2021.

Outbound Investments

Clorox divested its Better Health Vitamins, Minerals and Supplements (VMS) business.
The company also divested its business operations in Argentina.
Clorox is in the process of settling its Glad joint venture with Procter & Gamble, where it will acquire P&G's 20% stake.

Capital Expenditures

Clorox's capital expenditures for the latest twelve months ending June 30, 2025, were $220 million.
Capital expenditures averaged $248.4 million for fiscal years ending June 2021 to 2025.
The company is investing $500 million over the next few years in transformative technologies and processes, including a new enterprise resource planning (ERP) system and a transition to a cloud-based platform, with these investments commencing in fiscal year 2022.

	Best Bets In Consumer Staples Sector
What You Pay
P/E	19.1
P/EBIT	13.8
What You Get
Rev Chg Q	-18.9%
Rev Chg LTM	-9.3%
Rev Chg 3Y Avg	-1.1%
FCF/Rev 3Y Avg	9.9%

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Is Clorox Stock Poised for a Rally?	Actionable
2	5-Day Rally Sends Clorox Stock Up 9.5%	Notification
3	Clorox Stock: High Cash Flow - Why Not Watch It?	Actionable
4	How Low Can Clorox Stock Really Go?	Return
5	Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/6/2025]	Notification
6	Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/5/2025]	Notification
7	Day 5 of Gains Streak for Clorox Stock with 7.7% Return (vs. -20% YTD) [9/5/2025]	Notification
8	Clorox vs Merck: Which Is A Better Investment?	Counter-Intuitive Comparisons
9	Clorox vs Coca-Cola Consolidated: Which Is A Better Investment?	Counter-Intuitive Comparisons
10	How Does Clorox Stock Stack Up Against Its Peers?	Peer Comparison
11	ARTICLES
12	Could You Be Missing Clorox Stock’s Upside?		November 27th, 2025
13	Clorox Stock Rockets 9.5% With 5-Day Winning Streak		November 27th, 2025
14	Is Clorox Stock Poised for a Rally?		November 12th, 2025
15	S&P 500 Stocks Trading At 52-Week Low		November 11th, 2025
16	Is Clorox Stock Poised for a Rally?		November 4th, 2025

	Title
0	DASHBOARDS
1	Is Clorox Stock Poised for a Rally?
2	5-Day Rally Sends Clorox Stock Up 9.5%
3	Clorox Stock: High Cash Flow - Why Not Watch It?
4	How Low Can Clorox Stock Really Go?
5	Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/6/2025]
6	Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/5/2025]
7	Day 5 of Gains Streak for Clorox Stock with 7.7% Return (vs. -20% YTD) [9/5/2025]
8	Clorox vs Merck: Which Is A Better Investment?
9	Clorox vs Coca-Cola Consolidated: Which Is A Better Investment?
10	How Does Clorox Stock Stack Up Against Its Peers?
11	ARTICLES
12	Could You Be Missing Clorox Stock’s Upside?
13	Clorox Stock Rockets 9.5% With 5-Day Winning Streak
14	Is Clorox Stock Poised for a Rally?
15	S&P 500 Stocks Trading At 52-Week Low
16	Is Clorox Stock Poised for a Rally?

Trade Ideas

Select past ideas related to CLX. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
BF-B_11302025_Dip_Buyer_ValueBuy	11302025	BF-B	Brown-Forman	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	3.1%	3.1%	0.0%
CPB_11302025_Dip_Buyer_ValueBuy	11302025	CPB	Campbell's	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-1.9%	-1.9%	-1.9%
ENR_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	11212025	ENR	Energizer	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-5.3%	-5.3%	-5.3%
FLO_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	11212025	FLO	Flowers Foods	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	3.5%	3.5%	-1.6%
CLX_11142025_Dip_Buyer_FCFYield	11142025	CLX	Clorox	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	2.1%	2.1%	-5.1%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
BF-B_11302025_Dip_Buyer_ValueBuy	11302025	BF-B	Brown-Forman	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	3.1%	3.1%	0.0%
CPB_11302025_Dip_Buyer_ValueBuy	11302025	CPB	Campbell's	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-1.9%	-1.9%	-1.9%
ENR_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	11212025	ENR	Energizer	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-5.3%	-5.3%	-5.3%
FLO_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	11212025	FLO	Flowers Foods	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	3.5%	3.5%	-1.6%
CLX_11142025_Dip_Buyer_FCFYield	11142025	CLX	Clorox	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	2.1%	2.1%	-5.1%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
MPLT	MapLight Therapeutics	0.7	31.3%
AEVA	Aeva Technologies	0.8	25.7%	188.2%
DC	Dakota Gold	0.6	19.7%	150.9%
SERV	Serve Robotics	0.7	18.2%	-12.6%
ACDC	ProFrac	0.7	17.6%	-45.0%
HY	Hyster Yale	0.6	15.6%	-29.9%
AEO	American Eagle Outfitters	4.1	15.1%	49.7%
BEAM	Beam Therapeutics	2.7	14.4%	7.8%
GOSS	Gossamer Bio	0.8	14.4%	278.1%
FTRE	Fortrea	1.3	14.4%	-21.8%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
PSTG	Pure Storage	22.6	-27.3%	12.1%
GTLB	GitLab	6.3	-12.8%	-32.9%
CTEV	Claritev	0.7	-11.3%
FBYD	Falcons Beyond Global	0.7	-11.2%	131.2%
ACHC	Acadia Healthcare	1.3	-10.9%	-63.0%
ULS	UL Solutions	16.0	-10.7%	60.4%
HPK	HighPeak Energy	0.7	-10.6%	-59.8%
OS	OneStream	3.5	-10.4%	-35.0%
ARE	Alexandria Real Estate Equities	8.2	-10.1%	-47.9%
THO	Thor Industries	5.3	-9.5%	6.6%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
HPP	Hudson Pacific Properties	6.3	641.5%	-34.3%
TLRY	Tilray Brands	7.5	618.1%	-46.9%
TMC	TMC The Metals	2.8	42.2%	589.3%
VERA	Vera Therapeutics	2.6	40.2%	-2.4%
ARWR	Arrowhead Pharmaceuticals	9.0	39.1%	246.1%
TE	T1 Energy	0.7	37.4%
MPLT	MapLight Therapeutics	0.7	32.1%
AEVA	Aeva Technologies	0.8	31.1%	188.2%
AMKR	Amkor Technology	10.9	30.2%	73.4%
DC	Dakota Gold	0.6	30.2%	150.9%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
JANX	Janux Therapeutics	1.1	-50.7%	-68.0%
VTYX	Ventyx Biosciences	0.6	-25.0%	258.0%
CTEV	Claritev	0.7	-23.5%
AMBA	Ambarella	3.0	-22.9%	-3.6%
FULC	Fulcrum Therapeutics	0.6	-21.5%	92.8%
PD	PagerDuty	1.1	-20.5%	-33.9%
NTNX	Nutanix	12.7	-19.3%	-22.4%
CNK	Cinemark	2.6	-18.0%	-25.2%
PSTG	Pure Storage	22.6	-17.2%	12.1%
ZS	Zscaler	38.1	-15.9%	35.1%

1 Month Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
OLMA	Olema Pharmaceuticals	2.3	223.6%	367.4%
COGT	Cogent Biosciences	5.4	152.6%	402.1%
CDTX	Cidara Therapeutics	5.9	115.1%	722.1%
IRWD	Ironwood Pharmaceuticals	0.6	100.5%	-15.8%
TERN	Terns Pharmaceuticals	2.5	95.9%	396.2%
FRGE	Forge Global	0.6	90.3%	217.8%
SGML	Sigma Lithium	1.1	87.3%	-10.6%
INSP	Inspire Medical Systems	4.0	82.8%	-27.3%
NPCE	NeuroPace	0.6	77.2%	48.9%
ALMS	Alumis	0.6	71.9%	-0.3%

1 Month Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
UP	Wheels Up Experience	0.4	-52.7%	-62.4%
CCOI	Cogent Communications	0.9	-51.9%	-72.9%
SMR	NuScale Power	3.0	-50.7%	12.3%
FRMI	Fermi	10.3	-47.5%
AMSC	American Superconductor	1.4	-47.2%	30.1%
TLRY	Tilray Brands	7.5	-46.1%	-46.9%
BTDR	Bitdeer Technologies	2.4	-44.8%	-41.8%
EXOD	Exodus Movement	0.4	-43.1%	-53.3%
STUB	Stubhub	3.5	-39.8%
METC	Ramaco Resources	1.0	-39.4%	66.9%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
MPLT	MapLight Therapeutics	0.7	31.3%
AEVA	Aeva Technologies	0.8	25.7%	188.2%
DC	Dakota Gold	0.6	19.7%	150.9%
SERV	Serve Robotics	0.7	18.2%	-12.6%
ACDC	ProFrac	0.7	17.6%	-45.0%
HY	Hyster Yale	0.6	15.6%	-29.9%
AEO	American Eagle Outfitters	4.1	15.1%	49.7%
BEAM	Beam Therapeutics	2.7	14.4%	7.8%
GOSS	Gossamer Bio	0.8	14.4%	278.1%
FTRE	Fortrea	1.3	14.4%	-21.8%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
PSTG	Pure Storage	22.6	-27.3%	12.1%
GTLB	GitLab	6.3	-12.8%	-32.9%
CTEV	Claritev	0.7	-11.3%
FBYD	Falcons Beyond Global	0.7	-11.2%	131.2%
ACHC	Acadia Healthcare	1.3	-10.9%	-63.0%
ULS	UL Solutions	16.0	-10.7%	60.4%
HPK	HighPeak Energy	0.7	-10.6%	-59.8%
OS	OneStream	3.5	-10.4%	-35.0%
ARE	Alexandria Real Estate Equities	8.2	-10.1%	-47.9%
THO	Thor Industries	5.3	-9.5%	6.6%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
HPP	Hudson Pacific Properties	6.3	641.5%	-34.3%
TLRY	Tilray Brands	7.5	618.1%	-46.9%
TMC	TMC The Metals	2.8	42.2%	589.3%
VERA	Vera Therapeutics	2.6	40.2%	-2.4%
ARWR	Arrowhead Pharmaceuticals	9.0	39.1%	246.1%
TE	T1 Energy	0.7	37.4%
MPLT	MapLight Therapeutics	0.7	32.1%
AEVA	Aeva Technologies	0.8	31.1%	188.2%
AMKR	Amkor Technology	10.9	30.2%	73.4%
DC	Dakota Gold	0.6	30.2%	150.9%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
JANX	Janux Therapeutics	1.1	-50.7%	-68.0%
VTYX	Ventyx Biosciences	0.6	-25.0%	258.0%
CTEV	Claritev	0.7	-23.5%
AMBA	Ambarella	3.0	-22.9%	-3.6%
FULC	Fulcrum Therapeutics	0.6	-21.5%	92.8%
PD	PagerDuty	1.1	-20.5%	-33.9%
NTNX	Nutanix	12.7	-19.3%	-22.4%
CNK	Cinemark	2.6	-18.0%	-25.2%
PSTG	Pure Storage	22.6	-17.2%	12.1%
ZS	Zscaler	38.1	-15.9%	35.1%

Peer Comparisons for Clorox

Peers to compare with:

Financials

	CLX	PG	CL	KMB	ENTG	EPC	Median
Name	Clorox	Procter .	Colgate-.	Kimberly.	Entegris	Edgewell.
Mkt Price	-	-	-	-	-	-	-
Mkt Cap	-	-	-	-	-	-	-
Rev LTM	-	-	-	-	-	-	-
Op Inc LTM	-	-	-	-	-	-	-
FCF LTM	-	-	-	-	-	-	-
FCF 3Y Avg	-	-	-	-	-	-	-
CFO LTM	-	-	-	-	-	-	-
CFO 3Y Avg	-	-	-	-	-	-	-

Growth & Margins

	CLX	PG	CL	KMB	ENTG	EPC	Median
Name	Clorox	Procter .	Colgate-.	Kimberly.	Entegris	Edgewell.
Rev Chg LTM	-	-	-	-	-	-	-
Rev Chg 3Y Avg	-	-	-	-	-	-	-
Rev Chg Q	-	-	-	-	-	-	-
QoQ Delta Rev Chg LTM	-	-	-	-	-	-	-
Op Mgn LTM	-	-	-	-	-	-	-
Op Mgn 3Y Avg	-	-	-	-	-	-	-
QoQ Delta Op Mgn LTM	-	-	-	-	-	-	-
CFO/Rev LTM	-	-	-	-	-	-	-
CFO/Rev 3Y Avg	-	-	-	-	-	-	-
FCF/Rev LTM	-	-	-	-	-	-	-
FCF/Rev 3Y Avg	-	-	-	-	-	-	-

Valuation

	CLX	PG	CL	KMB	ENTG	EPC	Median
Name	Clorox	Procter .	Colgate-.	Kimberly.	Entegris	Edgewell.
Mkt Cap	-	-	-	-	-	-	-
P/S	-	-	-	-	-	-	-
P/EBIT	-	-	-	-	-	-	-
P/E	-	-	-	-	-	-	-
P/CFO	-	-	-	-	-	-	-
Total Yield	-	-	-	-	-	-	-
Dividend Yield	-	-	-	-	-	-	-
FCF Yield 3Y Avg	-	-	-	-	-	-	-
D/E	-	-	-	-	-	-	-
Net D/E	-	-	-	-	-	-	-

Returns

	CLX	PG	CL	KMB	ENTG	EPC	Median
Name	Clorox	Procter .	Colgate-.	Kimberly.	Entegris	Edgewell.
1M Rtn	-	-	-	-	-	-	-
3M Rtn	-	-	-	-	-	-	-
6M Rtn	-	-	-	-	-	-	-
12M Rtn	-	-	-	-	-	-	-
3Y Rtn	-	-	-	-	-	-	-
1M Excs Rtn	-	-	-	-	-	-	-
3M Excs Rtn	-	-	-	-	-	-	-
6M Excs Rtn	-	-	-	-	-	-	-
12M Excs Rtn	-	-	-	-	-	-	-
3Y Excs Rtn	-	-	-	-	-	-	-

Comparison Analyses

	Title
0	How Does Clorox Stock Stack Up Against Its Peers?
1	CLX Could Deliver 9.4% Returns And Outperform KMB
2	EPC or CLX - With 9.4% Return Forecast, CLX Probably Deserves Your Money
3	CL Looks Stronger Than CLX With 11% Return Potential
4	Clorox vs. Fortinet: With Return Forecast Of 31%, Fortinet Is A Better Bet
5	Clorox vs. Keurig Dr Pepper: With Return Forecast Of 83%, Keurig Dr Pepper Is A Better Bet
6	Clorox vs. Veeva Systems: With Return Forecast Of 66%, Veeva Systems Is A Better Bet
7	Clorox vs. Ross Stores: With Return Forecast Of 37%, Ross Stores Is A Better Bet
8	Clorox vs. Exelon: With Return Forecast Of 21%, Clorox Is A Better Bet
9	Clorox vs. Zoetis: Similar Revenue, Similar Bets

Financials

Annual
Quarterly

$ Mil \| FY: 6/30	LTM	2025	2024	2023	2022	2021	2020
Period End	9/30/2025	6/30/2025	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020
Filing Date	11/3/2025	8/8/2025	8/8/2024	8/10/2023	8/10/2022	8/10/2021	8/13/2020
Key Financials
Total Revenue	6,771	7,104	7,093	7,389	7,107	7,341	6,721
EBITDA	1,319	1,385	723	564	937	1,210	1,464
Operating Income	1,009	1,177	723	823	719	1,225	1,261
Net Income	791	810	280	149	462	710	939
EPS	6.41	6.56	2.26	1.21	3.75	5.66	7.46
Growth Rates
Total Revenue Growth	-9.3%	0.2%	-4.0%	4.0%	-3.2%	9.2%	8.2%
EBITDA Growth	52.7%	91.6%	28.2%	-39.8%	-22.6%	-17.3%	12.5%
Operating Income Growth	5.4%	62.8%	-12.2%	14.5%	-41.3%	-2.9%	13.9%
Net Income Growth	121.6%	189.3%	87.9%	-67.7%	-34.9%	-24.4%	14.5%
Margins
EBITDA Margin	19.5%	19.5%	10.2%	7.6%	13.2%	16.5%	21.8%
Operating Income Margin	14.9%	16.6%	10.2%	11.1%	10.1%	16.7%	18.8%
Net Income Margin	11.7%	11.4%	3.9%	2.0%	6.5%	9.7%	14.0%
Cash & Debt
Total Cash	166	167	202	367	183	319	871
Total Debt	3,078	2,880	2,903	2,924	3,103	3,166	3,122
Net Debt / (Cash)	2,912	2,713	2,701	2,557	2,920	2,847	2,251
Cash Flows
Net Cash from Operations	853	981	695	1,158	786	1,276	1,546
Free Cash from Operations	636	761	483	930	535	945	1,292
Returns to Shareholders
Dividends	602	602	595	583	571	558	533
Share Repurchases	354	332	-0	-0	25	905	248

$ Mil \| FY: 6/30	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2
Period End	9/30/2025	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022
Filing Date	11/3/2025	8/8/2025	5/5/2025	2/3/2025	10/30/2024	8/8/2024	4/30/2024	2/1/2024	11/1/2023	8/10/2023	5/2/2023	2/2/2023
Key Financials Quarterly
Total Revenue	1,429	1,988	1,668	1,686	1,762	1,903	1,814	1,990	1,386	2,019	1,915	1,715
Ebitda	186	489	332	312	252	355	38	219	111	320	-161	211
Operating Income	120	420	238	231	288	310	211	148	62	254	248	149
Net Income	80	332	186	193	99	216	-51	93	22	176	-211	99
EPS	0.65	2.70	1.51	1.55	0.80	1.74	-0.41	0.75	0.17	1.43	-1.71	0.81
Key Financials TTM
Total Revenue TTM	6,771	7,104	7,019	7,165	7,469	7,093	7,209	7,310	7,035	7,389	7,171	7,065
Ebitda TTM	1,319	1,385	1,251	957	864	723	688	489	481	564	467	906
Operating Income TTM	1,009	1,177	1,067	1,040	957	731	675	712	713	823	721	705
Net Income TTM	791	810	694	457	357	280	240	80	86	149	74	435
Growth Rates Quarterly
Total Revenue Growth	-18.9%	4.5%	-8.0%	-15.3%	27.1%	-5.7%	-5.3%	16.0%	-20.3%	12.1%	5.9%	1.4%
EBITDA Growth	-26.2%	37.7%	773.7%	42.5%	127.0%	10.9%	123.6%	3.8%	-42.8%	43.5%	-157.9%	23.4%
Operating Income Growth	-58.3%	35.5%	12.8%	56.1%	364.5%	22.0%	-14.9%	-0.7%	-64.0%	67.1%	6.9%	28.4%
Net Income Growth	-19.2%	53.7%	464.7%	107.5%	350.0%	22.7%	75.8%	-6.1%	-74.1%	74.3%	-240.7%	43.5%
Margins Quarterly
EBITDA Margin	13.0%	24.6%	19.9%	18.5%	14.3%	18.7%	2.1%	11.0%	8.0%	15.8%	-8.4%	12.3%
Operating Income Margin	8.4%	21.1%	14.3%	13.7%	16.3%	16.3%	11.6%	7.4%	4.5%	12.6%	13.0%	8.7%
Net Income Margin	5.6%	16.7%	11.2%	11.4%	5.6%	11.4%	-2.8%	4.7%	1.6%	8.7%	-11.0%	5.8%
Cash & Debt
Total Cash	166	167	226	290	278	202	219	355	518	367	242	168
Total Debt	3,078	2,880	2,944	3,092	2,884	2,903	3,020	3,129	3,203	2,924	3,025	3,083
Net Debt / (Cash)	2,912	2,713	2,718	2,802	2,606	2,701	2,801	2,774	2,685	2,557	2,783	2,915
Cash Flows Quarterly
FCF from Operations	93	294	286	180	221	340	182	153	20	430	341	209
Cash Flows TTM
FCF from Operations TTM	853	981	1,027	923	896	695	785	944	1,000	1,158	1,063	951
Returns to Shareholders Quarterly
Dividends	151	150	150	151	151	149	148	149	149	146	146	146
Share Repurchases	129	75	-0	150	107	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	12.6%	50.7%	26.3%	27.0%	25.7%	36.9%	30.1%	15.1%	8.0%	30.3%	30.4%	16.0%
Return on Invested Capital (ROIC) TTM
ROIC TTM	27.6%	33.2%	29.5%	26.8%	24.9%	19.9%	16.9%	15.2%	17.4%	21.8%	16.7%	18.7%

Segment Financials

Revenue by Segment

$ Mil	2025	2024	2023	2022	2021
Health and Wellness	2,485	2,532	2,427	2,980	2,749
Household	1,950	2,098	1,984	1,981	1,795
Lifestyle	1,275	1,338	1,253	1,218	1,154
International	1,162	1,181	1,180	1,162	1,023
Corporate and Other	221	240	263
Total	7,093	7,389	7,107	7,341	6,721

Assets by Segment

$ Mil	2025	2024	2023	2022	2021
International	1,327	1,410	1,453	1,489	1,010
Health and Wellness	1,124	1,184	1,275	2,043	2,145
Lifestyle	1,110	1,091	1,035	1,011	956
Corporate and Other	1,102	1,178	1,350	879	1,292
Household	1,088	1,082	1,045	912	810
Total	5,751	5,945	6,158	6,334	6,213

Price Behavior

Price Behavior

Market Price	$105.17
Market Cap ($ Bil)	12.9
First Trading Date	03/21/1983
Distance from 52W High	-35.7%
	50 Days	200 Days
DMA Price	$112.48	$125.63
DMA Trend	down	down
Distance from DMA	-6.5%	-16.3%
	3M	1YR
Volatility	22.9%	22.8%
Downside Capture	-17.69	37.03
Upside Capture	-79.84	-9.77
Correlation (SPY)	1.3%	19.5%

CLX Betas & Captures as of 11/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.30	0.02	-0.03	0.29	0.23	0.24
Up Beta	0.84	1.14	1.34	0.86	0.32	0.43
Down Beta	-0.96	-0.07	0.16	0.19	0.21	0.12
Up Capture	-3%	-64%	-55%	-11%	-5%	2%
Bmk +ve Days	12	25	38	73	141	426
Stock +ve Days	8	16	27	56	118	373
Down Capture	57%	11%	-40%	51%	46%	47%
Bmk -ve Days	7	16	24	52	107	323
Stock -ve Days	10	24	34	68	129	375

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

1Y 5Y 10Y

Based On 1-Year Data

		Comparison of CLX With Other Asset Classes (Last 1Y)
	CLX	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-34.7%	-2.9%	15.3%	58.9%	4.6%	-5.8%	-3.1%
Annualized Volatility	22.7%	13.9%	19.7%	19.4%	15.9%	17.8%	35.7%
Sharpe Ratio	-1.94	-0.45	0.60	2.26	0.09	-0.48	0.04
Correlation With Other Assets		63.2%	19.7%	-5.3%	-5.4%	44.5%	9.3%

ETFs used for asset classes: Sector ETF = XLP, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

		Comparison of CLX With Other Asset Classes (Last 5Y)
	CLX	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-9.2%	5.9%	15.0%	17.9%	11.9%	4.9%	37.1%
Annualized Volatility	25.0%	13.0%	17.1%	15.5%	18.9%	19.0%	49.1%
Sharpe Ratio	-0.39	0.26	0.71	0.93	0.52	0.17	0.64
Correlation With Other Assets		52.4%	18.1%	-0.6%	-9.1%	27.5%	1.9%

Based On 10-Year Data

		Comparison of CLX With Other Asset Classes (Last 10Y)
	CLX	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	1.1%	7.5%	14.5%	14.2%	5.6%	5.4%	76.3%
Annualized Volatility	23.7%	14.7%	18.0%	14.8%	17.7%	20.9%	55.9%
Sharpe Ratio	0.05	0.38	0.69	0.79	0.25	0.23	0.95
Correlation With Other Assets		54.5%	23.3%	3.6%	-4.4%	28.1%	2.9%

Short Interest

Short Interest: As Of Date	11142025
Short Interest: Shares Quantity	6,743,777
Short Interest: % Change Since 10312025	2.4%
Average Daily Volume	2,397,297
Days-to-Cover Short Interest	2.81
Basic Shares Quantity	122,629,000
Short % of Basic Shares	5.5%

Returns Analyses

	Title
0	How Low Can Clorox Stock Really Go?
1	CLX YTD Stock Return Of -100% Underperforms CL by 0% and Underperforms CL by 0%
2	Clorox Stock Return Comparison
3	Clorox Total Shareholder Return (TSR): 16.2% in 2023 and -7.5% 3-yr returns (below peer average)

SEC Filings

Expand for More

Report Date	Filing Date	Filing
9302025	11032025	10-Q 9/30/2025
6302025	8082025	10-K 6/30/2025
3312025	5052025	10-Q 3/31/2025
12312024	2032025	10-Q 12/31/2024
9302024	10302024	10-Q 9/30/2024
6302024	8082024	10-K 6/30/2024
3312024	4302024	10-Q 3/31/2024
12312023	2012024	10-Q 12/31/2023
9302023	11012023	10-Q 9/30/2023
6302023	8102023	10-K 6/30/2023
3312023	5022023	10-Q 3/31/2023
12312022	2022023	10-Q 12/31/2022
9302022	11012022	10-Q 9/30/2022
6302022	8102022	10-K 6/30/2022
3312022	5022022	10-Q 3/31/2022
12312021	2032022	10-Q 12/31/2021

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Clorox (CLX)

Market Price (12/4/2025): $105.43 | Market Cap: $12.9 BilSector: Consumer Staples | Industry: Household Products

Clorox (CLX)

Market Price (12/4/2025): $105.43Market Cap: $12.9 BilSector: Consumer StaplesIndustry: Household Products

Valuation, Metrics & Events

CLX Stock

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Clorox (CLX)

Share Repurchases

Share Issuance

Outbound Investments

Capital Expenditures

Interactive Breakdown

Better Bets than Clorox (CLX)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Clorox

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Based On 1-Year Data

Based On 5-Year Data

Based On 10-Year Data

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (12/4/2025): $105.43 | Market Cap: $12.9 Bil
Sector: Consumer Staples | Industry: Household Products

Market Price (12/4/2025): $105.43
Market Cap: $12.9 Bil
Sector: Consumer Staples
Industry: Household Products